On Friday 7 April at 3:30 pm Professor Madeleine King, the Cancer Australia Chair in Cancer Quality of Life (QOL) and Director of the QOL Office will give a webinar titled Interpreting Quality of Life and other Patient Reported Outcomes.
The Quality of Life (QOL) Office is funded by Cancer Australia to provide advice and support to members of Cancer Clinical Trials Groups (CCTGs) on assessing patient-reported outcomes (PROs) in their trials.
QOL and other PROs provide information about the impact of disease and treatment on the patient.
QOL/PROs should be interpreted in the context of other trial outcomes to provide a comprehensive assessment of treatment benefits and harms. Statistical significance alone is not a sufficient means of interpreting changes in PRO scores in a way that is clinically meaningful.
In this presentation with live webinar you will learn:
- How to interpret QOL PROs in a clinically meaningful way
- Current approaches to determining the smallest difference in a PRO that matters